Clinical Trials
5 trialsNCT03052127 2024-02-01
Study in Subjects With Small Primary Choroidal Melanoma
Aura Biosciences
Phase 1/2 Completed
NCT04589832 2023-11-22
Study of PAC-1 and Entrectinib for Patients With Metastatic Uveal Melanoma
Hoosier Cancer Research Network
Phase 1/2 Terminated
NCT02743611 2023-10-05
Safety & Activity of Controllable PRAME-TCR Therapy in Previously Treated AML/MDS or Metastatic Uveal Melanoma
Bellicum Pharmaceuticals
Phase 1/2 Terminated
NCT02570308 2023-03-21
A Study of the Intra-Patient Escalation Dosing Regimen With IMCgp100 in Patients With Advanced Uveal Melanoma
Immunocore Ltd
Phase 1/2 Completed
NCT01801358 2020-09-16
A Phase Ib/II Study of AEB071 and MEK162 in Adult Patients With Metastatic Uveal Melanoma
Array BioPharma
Phase 1/2 Terminated